Member Info for Okehurst1

THG slumps after Goldman reportedly sells £180m worth of shares

Mon, 4th Oct 2021 10:58
(Sharecast News) - THG, formerly The Hut Group, slumped on Monday after US investment bank Goldman Sachs reportedly cut its shareholding in the company by a third in recent days.
According to the Mail on Sunday, Goldman has sold at least £180m worth of stock, while US investment firm The Capital Group has sold more than half its stake.

French bank Credit Agricole and Germany's Deutsche Bank have also significantly reduced their stakes, the Mail said.

E-commerce group THG floated on the London Stock Exchange just over year ago.

Omega BoD have had the heads up … it’s coming
All in place

Thanks Danl

Treeman
There is a business or two in the group, it’s just trying to value Ingenuity

The 35% fall in the value of the web site sector would have affected the M/cap with or workout question marks around the value of Ingenuity

When Son invested at £4.5B value - ingenuity standalone - then the rump was £3.5B circa, this could on a like for like basis be £2.5B today and add whatever value you think Ingenuity is ?

Nb not a holder but v interested in buying in
I don’t short check my history on LSE
Trying evaluate the buy in price.

Dani
SoftBank valued Ingenuity at £4.5B earlier this year ?
Suggest on 30X ARR it could attract £1B today ?Noticed you mentioned £800M

Assume at the time of the Son investment the m/cap was around £8B?

So £3.5B for websites / balance?
Since then the whole sector has fell quite a bit around 35%
Could be £2.5B today like for like ?

So £3.5B m/cap for the sum of the parts?

£2.60 a share ? Plus any further upside on Ingenuity if they can pull off other deals to increase ARR?

What do you think of above ? Am I missing something ?

‘Infection prevention and control measures to protect residents and staff continuing to provide free personal protective equipment (PPE) to protect against COVID-19 to the adult social care sector until the end of March 2022
providing regular asymptomatic COVID-19 testing’

https://www.gov.uk/government/news/additional-funding-to-help-adult-social-care-this-winter

This is all they disclose

‘Performance Characteristics
Two prospective clinical evaluations were undertaken in the UK to determine clinical performance of the KnowNow™ SARS-CoV-2 Rapid Antigen Test. A total of 441 specimens were collected and analysed against reference standard test methods, where time from onset of symptoms was no more than 7 days and the Ct value of PCR was less 28’

S&S is somewhat academic, the scientific diagnostic community / scientists focus on Ct ranges / viral load

Their website has a URL to a Lancet paper - but no reference to their own test with data of note

This was from 2020

https://www.uktech.news/news/covid-19-20201221

I’ve tried a few times to locate independent clinical data on the Vatic test
It’s not new as you can see from via the URL dates back 12 months
Obviously not passed Porton Down - as yet

Ct value / range / Viral load tables & fully independent
via FIND / Welcome Trust etc …. Like Mologic

TW, have you come across any validated Data ?

https://clinicaltrials.gov/ct2/show/NCT04733170

Good research via Tom

https://twitter.com/tom_the_bomb__/status/1444252251720228867?s=10

Looking positive

https://www.omegadx.com/News-Events

Tweeting expecting ‘MRHA HUA
20 redirects to new web site

Appreciate we have had moments like this before - and I may be proved wrong - but the new Chairman looks to be managing the corporate / investor relationship side in a professional manner.

The role of a Chairman within an AIM stock is somewhat overlooked, holding the executives ‘ feet to the fire ‘ they are only as good as their last bad job, as I say this new chap looks promising and has a decent CV

I don’t think he would be letting Tweets like last night be released -which is market sensitive news - without the BoD being confident in the message.

Soon find out if he wants his CV / future corporate opportunities curtailed by issuing misleading information
via Tweets

As with Colin , giving this guy the benefit of doubt.

Big Bang
Not without risk but my take this has moved up to 90% this is coming off - MHRA approval

We know the Mologic test is arguably the best / one of the best in the world, it’s been through extensive clinical trials and use ability study and it’s been at PD for over 3 weeks

Everything in place, 100M capacity to maximise the opportunity - we didn’t have this level 6 months ago even

Risk Reward but serious rerate on news of the
expected ‘ to secure MHRA HUA

‘MHRA approval expected following self-test use CE marking’

Now ‘Expected ‘ that is very bullish they must know something

This will rocket on below coming off , they are looking very very bullish

https://twitter.com/omegadiagnostic/status/1443649067884687365?s=10

Hi Bigbangs

The interesting bit for me was the fact the Government have been evaluating 54 tests and still on going, Antibody testing appears to be part of their on going Covid strategy going forward.

When we get HUA hopefully you pull it back

Sorry to hear that Hani that’s a big hit

‘Status Number of tests
Registered interest 26
Currently being evaluated 23
Evaluation concluded or paused 5
Evaluated technology 0
Total 54’